Eva Wardelmann

University Hospital Münster

Papers

1

Total Citations

12

H-Index

1

About

Eva Wardelmann is a pioneering surgeon whose research focuses on advancing minimally invasive techniques for esophageal cancer treatment. Her major contribution lies in refining robotic-assisted esophagectomy by integrating total mesoesophageal excision, a meticulous dissection method that enhances the likelihood of complete tumor removal (R0-resection). In her landmark 2024 study, she demonstrated that this combined approach yields superior oncological outcomes, with 12 citations highlighting its immediate impact on surgical practice. Wardelmann’s work addresses a critical challenge in esophageal cancer surgery—achieving clear margins while minimizing trauma—and her single-center experience provides a foundational model for broader adoption. Her research not only advances technical precision but also offers hope for improved survival rates in patients with this aggressive disease. As a rising voice in robotic surgery, Wardelmann is shaping the future of esophageal oncology, bridging innovation and clinical excellence to set new standards in patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer: A single-center experience
12 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University Hospital Münster

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago